argenx

Novartis’s recent €2.7 billion ($2.9 billion) offer for Morphosys is the very stuff of biotechnology. The medium-sized deal adds two clinical-stage cancer drug candidates to its pipeline. 

Both operate through epigenetic mechanisms – they aim to alter dysfunctional gene expression programs and thereby interfere with the signals that maintain cancer growth. Pelabresib, a potential first-in-class inhibitor of bromodomain and extra-terminal motif (BET) proteins, has completed a phase 3 trial in myelofibrosis, a rare bone marrow cancer which disrupts red blood cell production. Tulmimetostat (formerly CPI-0209), an inhibitor of enhancer of zeste homolog 2 (EZH2), is in phase 1/2 trials in solid and haematological cancers. 

Behind the headlines, of course, lies over 30 years of European biotechnology history. Morphosys was the flagship firm in Munich’s biotech cluster and for long a leader in antibody discovery and development. It entered a string of large-scale deals with the likes of Novartis (again), Roche, GSK, Celgene (now Bristol Myers Squibb), and Johnson & Johnson.

Although its HuCal platform did deliver at least one blockbuster, in the form of J&J’s interleukin-23 inhibitor Tremfya (guselkumab), Morphosys failed ultimately to capture sufficient value to secure its future as a standalone antibody developer – unlike its more successful European rivals Genmab and Argenx. CEO Jean-Paul Kress and his team executed a bold pivot in 2021 by buying Constellation Pharmaceuticals for $1.7 billion and jettisoning Morphosys’s antibody heritage. That, essentially, is what Novartis is now buying. 

Companies mentioned in this episode:
Abbvie, Abbott Laboratories, Abcellera, Ablynx, Argenx, Celgene, Cambridge Antibody Technology, Constellation Pharmaceuticals, Chiron, Dyax, Genmab, GSK, Incyte, Johnson & Johnson, Morphosys, Novartis, Roche, Royalty Pharma, Xencor.

Get notified when new episodes are available

Disclaimer

© Smith & Sheridan 2024

Martine Hackett returns with a new season of “Untold Stories: Life with a Severe Autoimmune Condition.” Hear from people forging new paths after diagnosis, and learn how they build community and evolve their outlook on life. We’ll learn more about life with myasthenia gravis (MG) and chronic inflammatory demyelinating polyneuropathy (CIDP). Join us starting Wednesday, December 13th

See omnystudio.com/listener for privacy information.

While myasthenia gravis, or MG, can make navigating everyday tasks more difficult, it does not have to stop people living with MG from pursuing rich personal and professional lives. In this episode, Felicia and Sean talk about how they both remained driven as leaders in their industries while managing the debilitating condition. Often challenged by her MG symptoms, including vocal fatigue, Felicia learned how to find her voice and use it in new and powerful ways. She was able to build her consulting firm specifically helping entrepreneurs with disabilities start and grow their own businesses. Sean was an award-winning chef when his MG symptoms challenged his highly demanding lifestyle. Being forced to take time off showed him the value of taking breaks and ultimately, Sean learned new ways to be successful and mindful across all aspects of his life. They both share how they gained important lessons and powerful perspectives while learning to live with their MG.

See omnystudio.com/listener for privacy information.

Managing life with a rare disease like myasthenia gravis, or MG, can challenge the way you see yourself. Being mindful of emotional wellness can be as important as adapting to physical changes. Today’s guest, Eri, had to re-envision himself when his MG diagnosis challenged the role he played as a provider for his family and pillar in the community. Before the onset of his symptoms, he had never considered what challenges he would face in maintaining such a demanding life. By making lifestyle changes and cultivating a support system that strengthened his emotional well-being, Eri learned to prioritize his health alongside his responsibilities.

See omnystudio.com/listener for privacy information.

Myasthenia gravis, or MG, takes a toll on the lives of those living with the condition, but it also affects their loved ones. As Jessica and her husband Jonathan were preparing to welcome their second child into the world, they were not expecting to receive Jessica’s MG diagnosis. With this new element added to their lives, they have had to learn how to navigate their evolving family roles, nurture their marriage, and advocate for one another and themselves. In this episode, Jessica and Jonathan share how they have established a new balance in their life together.

See omnystudio.com/listener for privacy information.

In this special bonus episode, we’ll spotlight one of the many rare conditions that deserves more attention and resources. Chronic inflammatory demyelinating polyneuropathy, more commonly known as CIDP, is a rare neurological condition that causes progressive weakness, impaired mobility, and reduced sensation in the arms and legs. Guests, Scott and Crystal, discuss how each of their lives were drastically impacted by CIDP. When Scott, a choreographer, was diagnosed, he had to learn to channel his creativity into new mediums. While Crystal, a former pharmaceutical executive who was well-versed in rare conditions, found herself diagnosed with one. Despite their different backgrounds, they’ve both found that compassion, community, and continually engaging in proper care has taught them how to cope with the adjustments they have had to make in their lives.

See omnystudio.com/listener for privacy information.

Myasthenia gravis, or MG, affects people of all ages and races and is most commonly diagnosed later in life. However, for Anaya, her MG symptoms began when she was just 12 years old. Anaya went from being an active young athlete to struggling with immobility and school attendance. As a young black girl, Anaya’s age and race demographics complicated her MG diagnosis journey. However, by learning to advocate for herself and acknowledging her physical limitations, Anaya has been able to reframe her life with MG. She is now an ambitious college graduate and champion for other young people learning to live with this rare condition.

See omnystudio.com/listener for privacy information.

Navigating life with myasthenia gravis, or MG, often begins with a long road to diagnosis. For disabled veteran Shawna, the search for answers to her debilitating symptoms took several years. With the highs and lows of assistance from Veterans Affairs, she learned to navigate the healthcare system and make her voice heard, all while maintaining a positive outlook on her life with MG. Together with her caregiver and husband, Justin, Shawna has helped inspire the greater MG community with their blog, In Sickness and Nevermind, and redefined success for her own MG journey.

See omnystudio.com/listener for privacy information.

With a rare neuromuscular condition like myasthenia gravis, or MG, everyone’s experience with the disease is unique and often filled with struggles and sacrifices. That’s why argenx has partnered with iHeartRadio to bring you “Untold Stories: Life with Myasthenia Gravis.” In each episode, host Martine Hackett will explore the lessons learned and obstacles overcome by real people living with MG and share their empowering perspectives. Listen every other week to find strength and inspiration in these stories from members of the MG community.

See omnystudio.com/listener for privacy information.